Buscar
Mostrando ítems 11-20 de 436
Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
(The Brazilian Journal of Infectious Diseases and Contexto Publishing, 2008-04)
Histological response study of chronic viral hepatitis C patients treated with interferon alone or combined with ribavirin
(Brazilian Society of Infectious Diseases, 2008)
Chronic hepatitis C is often a progressive, fibrotic disease that can lead to cirrhosis and other complications. The recommended therapy is a combination of interferon and ribavirin. Besides its antiviral action, interferon ...
Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy
(Brazilian Society of Infectious Diseases, 2006-02-01)
Peginterferon alfa plus ribavirin is currently the treatment of choice for chronic hepatitis C. Peginterferon alfa-2a (40KD) plus ribavirin has given an overall sustained virological response of 18% in F3/F4 previous ...
Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy
(The Brazilian Journal of Infectious Diseases and Contexto Publishing, 2006-02)
Peginterferon alfa plus ribavirin is currently the treatment of choice for chronic hepatitis C. Peginterferon alfa-2a (40KD) plus ribavirin has given an overall sustained virological response of 18% in F3/F4 previous ...
Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
(The Brazilian Journal of Infectious Diseases and Contexto Publishing, 2008-04)
Hepatitis C (HCV) is now the main cause of chronic hepatic disease, cirrhosis and hepatocellular carcinoma. Several extrahepatic diseases have been associated with chronic HCV infection, and in most cases appear to be ...
Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
(Brazilian Society of Infectious Diseases, 2010)
Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition
(Medknow Publications, 2015-04)
AIM OF STUDY: In the present study, we evaluated the effect of ribavirin and metformin on the sensitivity of oxaliplatin and 5-fluorouracil (5-FU) on colon cancer.
MATERIALS AND METHODS: Cell viability of two commercially ...